• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Thursday

    4/7/22 1:16:22 PM ET
    $ABBV
    $ABC
    $ACAD
    $ACHC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Other Pharmaceuticals
    Health Care
    Get the next $ABBV alert in real time by email

     

     

    On Thursday, 75 stocks made new 52-week highs.

    Interesting Highlights From Today's 52-Week Lows:

    • The largest company by market cap to hit a new 52-week high was UnitedHealth Group (NYSE:UNH).
    • The smallest company in terms of market cap to set a new 52-week high was China Jo-Jo Drugstores (NASDAQ:CJJD).
    • China Jo-Jo Drugstores (NASDAQ:CJJD) was the biggest winner of the morning session, as it traded up 1123.11% to reach its new 52-week high.
    • Blue Ocean Acquisition (NASDAQ:BOCN) shares suffered the most, as they hit a 52-week high but moved 0.0% down thereafter.

    The following stocks created new 52-week highs on Thursday:

    • UnitedHealth Group (NYSE:UNH) shares were up 0.61% on Thursday morning to hit a new 52-week high of $536.57.
    • Johnson & Johnson (NYSE:JNJ) shares set a new yearly high of $182.69 this morning. The stock was up 0.15% on the session.
    • Walmart (NYSE:WMT) shares hit a yearly high of $156.56. The stock traded up 0.28% on the session.
    • AbbVie (NYSE:ABBV) shares hit a yearly high of $171.78. The stock traded up 1.46% on the session.
    • Eli Lilly (NYSE:LLY) shares set a new yearly high of $314.00 this morning. The stock was up 2.23% on the session.
    • Novo Nordisk (NYSE:NVO) stock on Thursday broke to a yearly high of $120.92. Shares traded up 2.74%.
    • Costco Wholesale (NASDAQ:COST) shares were up 2.46% on Thursday to hit a new 52-week high of $603.78 for a change of up 2.46%.
    • AstraZeneca (NASDAQ:AZN) shares set a new 52-week high of $69.85 on Thursday, moving up 0.94%.
    • Bristol-Myers Squibb (NYSE:BMY) shares set a new 52-week high of $76.28 on Thursday, moving up 0.88%.
    • Sanofi (NASDAQ:SNY) shares set a new 52-week high of $54.74 on Thursday, moving up 1.1%.
    • Anthem (NYSE:ANTM) shares hit a yearly high of $512.12. The stock traded up 0.75% on the session.
    • Regeneron Pharmaceuticals (NASDAQ:REGN) shares set a new yearly high of $723.49 this morning. The stock was up 1.92% on the session.
    • Aon (NYSE:AON) shares hit a yearly high of $332.73. The stock traded up 0.36% on the session.
    • America Movil (NYSE:AMX) shares were up 2.1% for the day, having made a 52-week high of $21.96.
    • Dollar Gen (NYSE:DG) stock set a new 52-week high of $241.35 Thursday morning. Over the session, the stock traded down 0.54%.
    • O'Reilly Automotive (NASDAQ:ORLY) shares reached a new 52-week high of $717.97 on Thursday morning, moving up 2.12%.
    • McKesson (NYSE:MCK) shares hit $314.13 on Thursday morning, setting a new 52-week high for a change of up 0.34%.
    • Hershey (NYSE:HSY) shares broke to $223.45 on Thursday, setting a new 52-week high with a change of up 0.2%.
    • HP (NYSE:HPQ) shares set a new yearly high of $41.47 this morning. The stock was up 15.55% on the session.
    • AutoZone (NYSE:AZO) stock made a new 52-week high of $2,130.63 Thursday. The stock was up 2.35% for the day.
    • Arthur J. Gallagher (NYSE:AJG) shares hit a yearly high of $180.71. The stock traded up 0.65% on the session.
    • Consolidated Edison (NYSE:ED) shares broke to a new 52-week high of $98.65 on Thursday. Shares of the company traded down 0.62%.
    • AmerisourceBergen (NYSE:ABC) shares were up 0.56% for the day, having made a 52-week high of $159.37.
    • Steris (NYSE:STE) stock on Thursday broke to a yearly high of $250.00. Shares traded down 0.08%.
    • Constellation Energy (NASDAQ:CEG) shares set a new 52-week high of $60.47 on Thursday, moving up 0.64%.
    • Alliant Energy (NASDAQ:LNT) shares broke to a new 52-week high of $65.24 on Thursday. Shares of the company traded down 1.15%.
    • Chesapeake Energy (NASDAQ:CHK) shares reached a new 52-week high of $92.73 on Thursday morning, moving up 0.02%.
    • Vistra (NYSE:VST) shares hit $24.01 on Thursday morning, setting a new 52-week high for a change of down 0.21%.
    • Acadia Healthcare Co (NASDAQ:ACHC) stock set a new 52-week high of $68.90 Thursday morning. Over the session, the stock traded up 0.29%.
    • Intra-Cellular Therapies (NASDAQ:ITCI) shares hit $65.94 on Thursday morning, setting a new 52-week high for a change of down 1.02%.
    • Idacorp (NYSE:IDA) shares were down 0.84% on Thursday morning to hit a new 52-week high of $118.79.
    • FTI Consulting (NYSE:FCN) stock set a new 52-week high of $163.95 Thursday morning. Over the session, the stock traded up 0.04%.
    • Grupo Simec (AMEX:SIM) shares hit $34.81 on Thursday morning, setting a new 52-week high for a change of up 8.1%.
    • Murphy USA (NYSE:MUSA) stock made a new 52-week high of $213.99 Thursday. The stock was up 1.66% for the day.
    • Black Hills (NYSE:BKH) shares hit a new 52-week high of $78.99. The stock traded down 0.83% on the session.
    • ONE Gas (NYSE:OGS) shares were down 0.94% for the day, having made a 52-week high of $91.79.
    • ACADIA Pharmaceuticals (NASDAQ:ACAD) shares broke to a new 52-week high of $28.05 on Thursday. Shares of the company traded down 0.17%.
    • Lantheus Holdings (NASDAQ:LNTH) stock made a new 52-week high of $60.23 Thursday. The stock was up 0.5% for the day.
    • Pacira BioSciences (NASDAQ:PCRX) shares broke to a new 52-week high of $81.69 on Thursday. Shares of the company traded up 2.47%.
    • PBF Energy (NYSE:PBF) stock on Thursday broke to a yearly high of $27.30. Shares traded down 1.26%.
    • MGE Energy (NASDAQ:MGEE) shares were down 1.21% on Thursday to hit a new 52-week high of $84.97 for a change of down 1.21%.
    • Zeta Global Holdings (NYSE:ZETA) shares set a new 52-week high of $13.43 on Thursday, moving up 10.7%.
    • Euronav (NYSE:EURN) shares set a new yearly high of $12.53 this morning. The stock was up 7.74% on the session.
    • Viper Energy Partners (NASDAQ:VNOM) shares achieved a new 52-week high on Thursday morning, hitting $31.89 with a daily change of down 1.09%.
    • MGP Ingredients (NASDAQ:MGPI) shares were up 2.17% for the day, having made a 52-week high of $95.41.
    • Amphastar Pharmaceuticals (NASDAQ:AMPH) stock set a new 52-week high of $39.89 Thursday morning. Over the session, the stock traded up 4.94%.
    • Sigma Lithium (NASDAQ:SGML) shares were up 7.35% for the day, having made a 52-week high of $17.98.
    • Intrepid Potash (NYSE:IPI) stock hit a yearly high price of $99.37. The stock was up 11.76% for the day.
    • BRC (NYSE:BRCC) shares hit $29.44 on Thursday morning, setting a new 52-week high for a change of up 7.73%.
    • Precision Drilling (NYSE:PDS) shares broke to $79.50 on Thursday, setting a new 52-week high with a change of up 1.13%.
    • Sierra Oncology (NASDAQ:SRRA) shares set a new 52-week high of $39.72 on Thursday, moving up 0.33%.
    • Berry (bry) (NASDAQ:BRY) shares achieved a new 52-week high on Thursday morning, hitting $11.86 with a daily change of up 4.19%.
    • Artivion (NYSE:AORT) shares were up 0.32% on Thursday to hit a new 52-week high of $22.46 for a change of up 0.32%.
    • Mirum Pharmaceuticals (NASDAQ:MIRM) stock hit a yearly high price of $27.38. The stock was up 1.72% for the day.
    • The Hackett Group (NASDAQ:HCKT) shares hit $23.99 on Thursday morning, setting a new 52-week high for a change of up 0.23%.
    • Duff & Phelps Global (NYSE:DPG) shares reached a new 52-week high of $15.45 on Thursday morning, moving down 1.81%.
    • Teekay Tankers (NYSE:TNK) shares hit $16.44 on Thursday morning, setting a new 52-week high for a change of up 4.74%.
    • Singularity Future (NASDAQ:SGLY) shares hit a new 52-week high of $18.79. The stock traded down 0.72% on the session.
    • FTAC Emerald (NASDAQ:EMLD) shares hit $9.83 on Thursday morning, setting a new 52-week high for a change of up 0.31%.
    • Innovative International (NASDAQ:IOAC) shares broke to a new 52-week high of $10.02 on Thursday. Shares of the company traded up 0.1%.
    • GigCapital5 (NYSE:GIA) stock made a new 52-week high of $10.04 Thursday. The stock was up 0.6% for the day.
    • Standard BioTools (NASDAQ:LAB) shares hit a new 52-week high of $3.89. The stock traded up 0.66% on the session.
    • UTA Acquisition (NASDAQ:UTAA) stock on Thursday broke to a yearly high of $10.14. Shares traded up 0.3%.
    • Weyco Group (NASDAQ:WEYS) shares broke to a new 52-week high of $25.98 on Thursday. Shares of the company traded down 0.64%.
    • Blue Ocean Acquisition (NASDAQ:BOCN) shares were 0.0% (flat) on Thursday to hit a new 52-week high of $9.91 for a change of 0.0% (flat).
    • Ventoux CCM Acquisition (NASDAQ:VTAQ) shares hit $10.16 on Thursday morning, setting a new 52-week high for a change of 0.0% (flat).
    • Ardmore Shipping (NYSE:ASC) shares hit a yearly high of $5.14. The stock traded up 2.89% on the session.
    • EdtechX Holdings (NASDAQ:EDTX) stock set a new 52-week high of $10.11 Thursday morning. Over the session, the stock traded up 0.1%.
    • Fintech Ecosystem Dev (NASDAQ:FEXD) stock made a new 52-week high of $9.98 Thursday. The stock was up 0.2% for the day.
    • Viveon Health Acq (AMEX:VHAQ) stock on Thursday broke to a yearly high of $10.23. Shares traded up 0.05%.
    • Kairous Acquisition Corp (NASDAQ:KACL) shares reached a new 52-week high of $9.93 on Thursday morning, moving 0.0% (flat).
    • Bull Horn Hldgs (NASDAQ:BHSE) shares broke to a new 52-week high of $10.10 on Thursday. Shares of the company traded up 0.2%.
    • Trevi Therapeutics (NASDAQ:TRVI) shares achieved a new 52-week high on Thursday morning, hitting $2.85 with a daily change of up 36.84%.
    • Sunshine Biopharma (NASDAQ:SBFM) shares set a new yearly high of $8.85 this morning. The stock was up 32.75% on the session.
    • China Jo-Jo Drugstores (NASDAQ:CJJD) shares hit $3.07 on Thursday morning, setting a new 52-week high for a change of up 1123.11%.

     

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ABBV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABBV
    $ABC
    $ACAD
    $ACHC

    CompanyDatePrice TargetRatingAnalyst
    Walmart Inc.
    $WMT
    2/27/2026$150.00Buy
    BofA Securities
    Costco Wholesale Corporation
    $COST
    2/27/2026$1185.00Buy
    BofA Securities
    Arthur J. Gallagher & Co.
    $AJG
    2/27/2026$260.00Neutral → Outperform
    Mizuho
    Aon plc
    $AON
    2/27/2026$397.00Neutral → Outperform
    Mizuho
    Lantheus Holdings Inc.
    $LNTH
    2/26/2026Mkt Perform → Outperform
    William Blair
    Eli Lilly and Company
    $LLY
    2/25/2026$1250.00Outperform
    RBC Capital Mkts
    Bristol-Myers Squibb Company
    $BMY
    2/25/2026$60.00Sector Perform
    RBC Capital Mkts
    AbbVie Inc.
    $ABBV
    2/25/2026$260.00Outperform
    RBC Capital Mkts
    More analyst ratings

    $ABBV
    $ABC
    $ACAD
    $ACHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Knight Lester B bought $1,276,956 worth of Class A Ordinary Stock (4,000 units at $319.24) (SEC Form 4)

    4 - Aon plc (0000315293) (Issuer)

    2/12/26 4:34:45 PM ET
    $AON
    Specialty Insurers
    Finance

    Vice President & Treasurer Bradley William Patrick Iii bought $44,870 worth of shares (3,250 units at $13.81) (SEC Form 4)

    4 - Duff & Phelps Utility & Infrastructure Fund Inc. (0001515671) (Issuer)

    2/10/26 4:32:59 PM ET
    $DPG
    Trusts Except Educational Religious and Charitable
    Finance

    Director Heron Patrick J acquired 159,277 shares and bought $8,999,984 worth of shares (131,425 units at $68.48) (SEC Form 4)

    4 - Mirum Pharmaceuticals, Inc. (0001759425) (Issuer)

    1/27/26 4:14:26 PM ET
    $MIRM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABBV
    $ABC
    $ACAD
    $ACHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities resumed coverage on Walmart with a new price target

    BofA Securities resumed coverage of Walmart with a rating of Buy and set a new price target of $150.00

    2/27/26 8:32:12 AM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    BofA Securities initiated coverage on Costco with a new price target

    BofA Securities initiated coverage of Costco with a rating of Buy and set a new price target of $1,185.00

    2/27/26 8:31:30 AM ET
    $COST
    Department/Specialty Retail Stores
    Consumer Discretionary

    Arthur J. Gallagher upgraded by Mizuho with a new price target

    Mizuho upgraded Arthur J. Gallagher from Neutral to Outperform and set a new price target of $260.00

    2/27/26 8:20:07 AM ET
    $AJG
    Specialty Insurers
    Finance

    $ABBV
    $ABC
    $ACAD
    $ACHC
    SEC Filings

    View All

    SEC Form 8-K filed by FTI Consulting Inc.

    8-K - FTI CONSULTING, INC (0000887936) (Filer)

    2/27/26 4:37:28 PM ET
    $FCN
    Professional Services
    Consumer Discretionary

    SEC Form 10-K filed by Hackett Group Inc.

    10-K - HACKETT GROUP, INC. (0001057379) (Filer)

    2/27/26 4:33:18 PM ET
    $HCKT
    Professional Services
    Consumer Discretionary

    SEC Form 6-K filed by Precision Drilling Corporation

    6-K - PRECISION DRILLING Corp (0001013605) (Filer)

    2/27/26 4:26:07 PM ET
    $PDS
    Oil & Gas Production
    Energy

    $ABBV
    $ABC
    $ACAD
    $ACHC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 28, 2025 - FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors

    For Immediate Release: March 28, 2025 Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B, with or without factor VIII or IX inhibitors (neutralizing antibodies).“Today’s approval of Qfitlia is significant for patients wi

    3/28/25 10:17:55 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    February 21, 2025 - FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease

    For Immediate Release: February 21, 2025 Today, the U.S. Food and Drug Administration approved Ctexli (chenodiol) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Ctexli is the first FDA-approved drug to treat CTX, a very rare lipid storage disease.“The FDA is dedicated to supporting new drug development for rare diseases including very rare metabolic diseases like cerebrotendinous xanthomato

    2/21/25 11:48:20 AM ET
    $MIRM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    February 14, 2025 - FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

    For Immediate Release: February 14, 2025 Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus. Merilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA. As a rapid-acting insulin, Meri

    2/14/25 3:00:13 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABBV
    $ABC
    $ACAD
    $ACHC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Precision Drilling Corporation Announces Dual Listing on NYSE Texas

    CALGARY, Alberta, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Precision Drilling Corporation ("Precision" or the "Company") (TSX:PD, NYSE:PDS) today announced that its common shares have been approved for dual listing on NYSE Texas, a fully electronic equities exchange headquartered in Dallas, Texas, which launched in March 2025. Precision will maintain its primary listing on the New York Stock Exchange (NYSE) and trade with the same "PDS" ticker symbol on NYSE Texas, effective March 2, 2026. The Company's common shares will also continue to trade on the Toronto Stock Exchange under the trading symbol "PD". About Precision Precision is a leading provider of safe and environmentally responsible Hi

    2/27/26 2:13:51 PM ET
    $PDS
    Oil & Gas Production
    Energy

    NYSE Content Update: Grindr Reports 28% Full Year Revenue Growth in Q4 Earnings

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 27, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Caroline Woods delivers the pre-market update on February 27thStocks are mixed Friday morning as investors digest fresh economic data including the January PPI Report and the latest comments from Federal Reserve policymakers.Grindr (NYSE:GRND) released its latest earnings following Thursday's market close, revealing that its revenue jumped by 28% in 2025.Zeta Global (NYSE:ZETA

    2/27/26 8:55:00 AM ET
    $GRND
    $ICE
    $QNC
    Computer Software: Programming Data Processing
    Technology
    Investment Bankers/Brokers/Service
    Finance

    Lilly's Olumiant (baricitinib) recommended by CHMP for approval of expanded use in the European Union for adolescents with severe alopecia areata

    The positive opinion is based on data from the Phase 3 BRAVE-AA-PEDS study, in which 42% of patients with severe alopecia areata (AA) reached 80% or more scalp hair coverage at 36 weeksThe study is the first and largest of its kind specifically designed to evaluate children and adolescents with severe AA, a disease that has devastating social and emotional impactLilly has also submitted Olumiant in the U.S. for approval to treat severe AA in adolescents, with a decision expected in the second half of 2026INDIANAPOLIS, Feb. 27, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Incyte (NASDAQ:INCY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Produ

    2/27/26 8:11:00 AM ET
    $INCY
    $LLY
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ABBV
    $ABC
    $ACAD
    $ACHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Walton Family Holdings Trust disposed of 303,000 units of Common and sold $220,133,909 worth of Common (1,723,236 units at $127.74), decreasing direct ownership by 0.39% to 522,580,949 units (SEC Form 4)

    4 - Walmart Inc. (0000104169) (Issuer)

    2/27/26 5:34:21 PM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Director Mcmillon C Douglas sold $2,460,118 worth of Common (19,416 units at $126.71), decreasing direct ownership by 0.48% to 4,023,209 units (SEC Form 4)

    4 - Walmart Inc. (0000104169) (Issuer)

    2/27/26 5:02:14 PM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    EVP, GC and Secretary Farley Brian covered exercise/tax liability with 1,915 shares, decreasing direct ownership by 3% to 69,165 units (SEC Form 4)

    4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

    2/27/26 5:01:02 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ABBV
    $ABC
    $ACAD
    $ACHC
    Financials

    Live finance-specific insights

    View All

    Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results

    — Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years — — Conference call today at 4:30 p.m. ET — BRISBANE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today reported financial results for the fourth quarter and full-year of 2025. "2025 was a year of disciplined execution for Pacira. With the launch of our 5x30 strategy, we reignited momentum across the business and delivered strong, measurable progress. Our products benefitted more than 2.5 million patients

    2/26/26 4:01:00 PM ET
    $PCRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FTI Consulting Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter 2025 Record Revenues of $990.7 Million, Up 11% Compared to $894.9 Million in Prior Year QuarterFourth Quarter 2025 EPS and Adjusted EPS of $1.78, Up 29% and 14%, Compared to EPS of $1.38 and Adjusted EPS of $1.56 in Prior Year Quarter Full Year 2025 Record Revenues of $3.789 Billion, Up 2% Compared to $3.699 Billion in Prior YearFull Year 2025 Record EPS of $8.24 and Adjusted EPS of $8.83, Up 6% and 11%, Compared to EPS of $7.81 and Adjusted EPS of $7.99 in Prior YearIntroduces 2026 Guidance WASHINGTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE:FCN) today released financial results for the full year and fourth quarter ended December 31, 2025. For the ful

    2/26/26 7:30:00 AM ET
    $FCN
    Professional Services
    Consumer Discretionary

    Vistra Reports Fourth Quarter and Full-Year 2025 Results

    Earnings Release HighlightsGAAP full-year 2025 Net Income of $944 million, including an unrealized loss from hedges expected to settle in future years of $808 million, and Cash Flow from Operations of $4,070 million.Ongoing Operations Adjusted EBITDA1 of $5,912 million and Ongoing Operations Adjusted FCFbG1 of $3,592 million, exceeding the midpoint of the original guidance range by approximately $112 million and approximately $292 million, respectively.2026 Ongoing Operations Adjusted EBITDA1 and Ongoing Operations Adjusted FCFbG1 guidance ranges of $6.8 billion to $7.6 billion and $3.925 billion to $4.725 billion, respectively, excluding any potential impact from the Cogentrix assets.Indust

    2/26/26 7:00:00 AM ET
    $VST
    Electric Utilities: Central
    Utilities

    $ABBV
    $ABC
    $ACAD
    $ACHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Blue Ocean Acquisition Corp

    SC 13G/A - Blue Ocean Acquisition Corp (0001856961) (Subject)

    12/9/24 4:49:04 PM ET
    $BOCN
    Blank Checks
    Finance

    Amendment: SEC Form SC 13G/A filed by Blue Ocean Acquisition Corp

    SC 13G/A - Blue Ocean Acquisition Corp (0001856961) (Subject)

    12/6/24 4:15:24 PM ET
    $BOCN
    Blank Checks
    Finance

    Amendment: SEC Form SC 13D/A filed by PBF Energy Inc.

    SC 13D/A - PBF Energy Inc. (0001534504) (Subject)

    12/2/24 5:14:26 PM ET
    $PBF
    Integrated oil Companies
    Energy

    $ABBV
    $ABC
    $ACAD
    $ACHC
    Leadership Updates

    Live Leadership Updates

    View All

    Dakota Gold Announces Appointment of Brian G. Iverson to Board of Directors

    Lead, South Dakota--(Newsfile Corp. - February 27, 2026) - Dakota Gold Corp. (NYSE:DC) ("Dakota Gold" or the "Company") is pleased to announce the appointment of Brian G. Iverson to its Board of Directors ("Board"), effective immediately. Mr. Iverson brings more than three decades of strategic leadership experience across legal, financial, regulatory, and corporate governance functions for South Dakotan companies. Mr. Iverson's local and professional experience compliment the Company's Board as Dakota Gold advances its exploration and development initiatives in South Dakota's historic Homestake District.Mr. Iverson currently serves as General Counsel and Senior Vice President Regulatory and

    2/27/26 6:30:00 AM ET
    $BKH
    $DC
    Electric Utilities: Central
    Utilities
    Metal Mining
    Basic Materials

    Arthur J. Gallagher & Co. Announces New Investor Relations Leader

    ROLLING MEADOWS, Ill., Feb. 24, 2026 /PRNewswire/ -- Arthur J. Gallagher & Co. today announced the appointment of Sara Walsh, CFA, to lead the Investor Relations team.  Sara has nearly two decades of tenure at Gallagher, where she began as a summer sales intern and has held positions of increasing responsibility in Corporate Finance and Treasury. She also serves as Gallagher's Treasurer and head of Corporate Finance, overseeing financial analysis and reporting, capital planning and communications with rating agencies, banks, and investment bankers, including leading all of Galla

    2/24/26 4:07:00 PM ET
    $AJG
    Specialty Insurers
    Finance

    Aviation and Aerospace Expert Scott Davidson Joins FTI Consulting as Senior Managing Director

    WASHINGTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE:FCN) today announced the appointment of Scott Davidson as a Senior Managing Director in the Aviation Business Transformation practice within the firm's Corporate Finance & Restructuring segment. Mr. Davidson, who is based in New York, has nearly two decades of experience advising airlines, aviation service providers, and aircraft and engine manufacturers on strategic, operational and commercial challenges. He has deep expertise regarding airline technical operations, ground operations and crew management, fleet planning, network planning, procurement support, product development and revenue management. In his role a

    2/18/26 8:30:00 AM ET
    $FCN
    Professional Services
    Consumer Discretionary